Children's Hospital of Orange County

Donate

Dr. Elyssa Rubin, Pediatric Oncology

Elyssa Rubin

Elyssa Rubin, MD

is on staff at
CHOC Hospital Orange

Appointments:
714-509-8636
Specialty:
Oncology
Board Certified:
Pediatrics, Hematology, Pediatric Hematology/Oncology

Oncology Referrals

Physicians can refer patients to CHOC through our eCeptionist Referral Portal.

Refer a Patient

With special interests in sarcomas, neuroblastoma and the histocytic disorders, Dr. Elyssa Rubin serves as the director of the Bone and Soft Tissue Tumor Program at CHOC Hospital and is an oncologist with CHOC Specialists.

Dr. Rubin is board certified in pediatrics and pediatric hematology/oncology. Dr. Rubin completed her medical school training at the Sackler School of Medicine, NY State/American Branch in Tel Aviv, Israel. She completed her pediatric internship and residency training at Kaiser Permanente Los Angeles Medical Center and her fellowship in pediatric hematology/oncology at CHOC Hospital in Orange. As a research fellow, Dr. Rubin’s focus was on new therapeutic targets for osteosarcoma.

“Curing the cancer and getting patients and families back to living their lives is the goal and is a truly meaningful part,” Dr. Rubin says. “Knowing that, despite what they’re going through or the outcome, I can possibly make it easier or have a positive impact for them in some way is meaningful.”

Location

Outpatient Clinic, Hyundai Cancer Institute at CHOC
1201 W. La Veta Avenue
Orange, CA 92868
phone: 714-509-8636
fax: 714-509-8699

Education

  • Medical School
    Sackler School of Medicine, NY State/American Branch, Tel Aviv, Israel
  • Pediatric Internship and Residency
    Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA
  • Fellowship
    Pediatric Hematology and Oncology at CHOC Hospital, Orange, CA

Academic Appointments

  • Assistant Professor of Pediatrics
    University of California, Irvine, School of Medicine

Administrative Appointments

  • Director, Bone and Soft Tissue Tumor Program, CHOC Hyundai Cancer Institute
  • Oncology, CHOC Specialists

Professional Organizations

  • American Association for Cancer Research (AACR)
  • American Society for Blood and Marrow Transplantation (ASBMT)
  • American Society of Clinical Oncology (ASCO)
  • American Society of Pediatric Hematology and Oncology (ASPHO)
  • Children’s Oncology Group (COG)
  • Connective Tissue Oncology Society (CTOS)
  • Histiocyte Association of America (HAA)

Publications

Buchbinder, D., Hsieh, L., Puthenveetil G., Soni A., Stites J., Huynh V., Kirov I., Neudorf S., Rubin E., Sender L., Torno L., Margolis D., Childs R., Moore T., Nugent D. Successful Autologous cord blood transplantation in a child with acquired severe aplastic anemia. Pediatr Transplant, 2013 May;17(3):E104-7. Doi: 10.1111/petr.12068. Epub 2013 Mar 7.

McQueen P, Ghaffar S, Guo Y, Rubin EM, Zi X, Hoang BH. The Wnt signaling pathway: implications for therapy in osteosarcoma. Expert Review of Anticancer Therapy. 11(8):1223-32 (2011). PMID 21916576

Rubin EM, Guo Y, Tu K, Xie J, Zi X, Hoang BH. Wnt inhibitory factor 1decreases tumorigenesis and metastasis in osteosarcoma, Mol Cancer Ther. 2010 Mar:9(3):731-41. Epub 2010 Mar 2. PMID: 20197388

 

Health Stories